INIS
patients
93%
glucose
61%
diseases
59%
risks
57%
people
46%
insulin
39%
levels
38%
adults
37%
data
36%
comparative evaluations
35%
populations
29%
metabolism
29%
reviews
28%
diabetes mellitus
27%
control
26%
liver
23%
quality of life
21%
sex
20%
men
19%
management
18%
plasma
17%
sensitivity
17%
symptoms
17%
ulcers
16%
women
16%
lipids
15%
guidelines
15%
arteries
14%
design
13%
interventions
13%
brain
13%
inflammation
13%
performance
12%
biological markers
12%
thyroid
12%
cardiovascular diseases
12%
muscles
11%
humans
11%
intake
10%
tumors
10%
fructose
10%
range
10%
carcinomas
10%
proteins
10%
monitoring
10%
adjustments
9%
assessments
9%
tolerance
9%
genes
9%
values
9%
therapy
9%
skin
9%
hormones
9%
obesity
8%
kidneys
8%
concentration
8%
regression analysis
8%
cholesterol
8%
blood pressure
8%
stiffness
8%
genetics
8%
fats
8%
blood
8%
healing
7%
receptors
7%
education
7%
cancer
7%
nerves
7%
thickness
7%
pancreas
7%
incidents
7%
mortality
7%
volume
7%
prediction
7%
losses
6%
adipose tissue
6%
recommendations
6%
diet
6%
metabolites
6%
sensors
6%
fasting
6%
children
6%
netherlands
6%
evaluation
6%
peptides
5%
oxidation
5%
sleep
5%
hazards
5%
adolescents
5%
clinical trials
5%
exercise
5%
fibers
5%
surgery
5%
triglycerides
5%
wounds
5%
screening
5%
density
5%
surveys
5%
bones
5%
velocity
5%
Keyphrases
Maastricht
100%
Type 2 Diabetes Mellitus (T2DM)
84%
Type 1 Diabetes Mellitus (T1DM)
30%
Hypoglycemia
30%
Diabetes
25%
Type I Diabetes
23%
Pre-diabetes (pre-DM)
21%
Patients with Diabetes
19%
Diabetic Foot
19%
Dutch
15%
Peripheral Arterial Disease
13%
Confidence Interval
13%
Multiple Endocrine Neoplasia Type 1 (MEN1)
13%
Type 2 Diabetic Patients
13%
Insulin Sensitivity
13%
International Working Groups
12%
Hemoglobin A1c (HbA1c)
12%
Quality of Life
11%
Physical Activity
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
10%
Normal Glucose Tolerance
10%
Diabetic Foot Ulcer
9%
Hepatic Fat
9%
Cardiovascular Disease
8%
Foot Ulcer
8%
Depressive Symptoms
8%
Cardiovascular Risk
8%
Randomized Controlled Trial
8%
Population-based Cohort Study
8%
Insulin
7%
Glycemic Control
7%
Fructose
7%
Insulin Resistance
7%
Arterial Stiffness
6%
Hypoglycemia Unawareness
6%
Non-associated
6%
Sedentary Behavior
6%
Netherlands
6%
Skeletal muscle
6%
Continuous Glucose Monitoring
6%
Risk Factors
6%
Hypo
6%
Cognitive Performance
6%
Odds Ratio
6%
Health-related Quality of Life
6%
Oral Glucose Tolerance Test
5%
Without Diabetes
5%
Endothelial Dysfunction
5%
Glucose Metabolism Status
5%
Placebo
5%
Sex Hormone-binding Globulin
5%
Hyperglycemia
5%
Healthcare Professionals
5%
Glucose Variability
5%
Advanced Glycation End Products
5%
Survivors
5%
Body Mass Index
5%
Microvascular Dysfunction
5%
Metformin
5%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
5%
Phenylketonuria
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
60%
Diabetes
38%
Impaired Glucose Tolerance
20%
Hypoglycemia
19%
Systematic Review
17%
Insulin Dependent Diabetes Mellitus
16%
Quality of Life
14%
Glucose Metabolism
13%
Physical Activity
12%
Arteriosclerosis Obliterans
12%
Multiple Endocrine Neoplasia Type I
11%
Diabetes Mellitus
11%
Cardiovascular Disease
11%
Biological Marker
10%
Arterial Stiffness
9%
Disease
9%
Cohort Analysis
8%
Depression
8%
Differentiated Thyroid Cancer
8%
Foot Ulcer
7%
Insulin Sensitivity
7%
Awareness
7%
Endothelial Dysfunction
6%
Foot Disease
6%
Prevalence
6%
Body Mass Index
6%
Cardiovascular System
6%
Diabetic Neuropathy
6%
Glycemic Control
5%
Nonalcoholic Fatty Liver
5%
Hemoglobin A1c
5%
Diabetic Foot Ulcer
5%
Randomized Controlled Trial
5%
Patient with Type 2 Diabetes
5%
Skeletal Muscle
5%
Oral Glucose Tolerance Test
5%
Amputation
5%
Fructose
5%